Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Eikon Therapeutics, Inc.
EIKN
Current ratio
Current ratio at other companies
Gilead Sciences
GILD
1.3×
0.0×
IDEAYA Biosciences, Inc.
IDYA
10.7×
-3.2×
Inhibrx Biosciences, Inc.
INBX
6.5×
+1.3×
OnKure Therapeutics, Inc.
OKUR
13.8×
+2.6×
Immunome
IMNM
21.7×
+11.2×
Erasca, Inc.
ERAS
9.5×
-2.8×
Other financials
Income statement
See full
Operating income
-$87.3M
-22.3%
Net income
-$83.0M
-21.6%
EPS (diluted)
-$2.46
+90.9%
Balance sheet
See full
Cash & equivalents
$161.2M
-21.2%
Total debt
$254.8M
—
Total equity
$550.7M
+186%
Total assets
$850.8M
—
Cash flow
See full
Operating cash flow
-$89.8M
-64.7%
CapEx
$262.0K
-98.8%
Free cash flow
-$90.1M
-17.1%
Valuation
See full
Market cap
$498.62M
-36.3%
Enterprise value
$592.29M
—
Returns & leverage
See full
Debt / equity
0.5×
—
Watchlist
Screener
Filings
Earnings
Charts